Scientific corner

S-05-06 Efficacy of Adsorptive Granulocyte/Monocyte Apheresis in Inflammatory Bowel Disease Patients Experiencing Loss of Response to Infliximab (poster)

ISFA-E-ISFA 2021

To our knowledge this is the first report of adding GMA to restore the efficacy of infliximab in patients with LoR.  However, the efficacy outcomes following addition of a non-drug GMA to infliximab is potentially very interesting in therapeutic settings and should inspire further studies

https://www.eventclass.org/contxt_eisfa2021/online-program/session?s=S-05

Scientific corner

Case Report: Combination Therapy With Granulocyte Apheresis and Infliximab for Refractory Crohn’s Disease

P. Gonzalez Carro, F. Perez Roldan, O. Roncero Garcıa Escribano,R. Lafuente, M.L. Legaz Huidobro, and A. Amigo Echenagusıa

Journal of Clinical Apheresis 21: 249–251 (2006)

To our knowledge, no cases of combined therapy with infliximab and granulocyte apheresis have been previously reported. Our results suggest that this combined therapy is a possible alternative to treat CD patients in the event of loss of response to infliximab.

https://onlinelibrary.wiley.com/doi/10.1002/jca.20093

Contact UsFor more information

Contact Us